Thyroid Eye Disease

Mycophenolate mofetil appears to be effective second-line treatment for thyroid eye disease

Mycophenolate mofetil (MMF) appears safe and effective as a second-line immunosuppressive agent in patients with thyroid eye disease (TED), according to a study. In this retrospective cohort study, 20 patients with active moderate-severe to sight-threatening TED were followed over 4 years (Weeks 24, 52 and 78) to evaluate the clinical efficacy of...